Prosecution Insights
Last updated: November 04, 2026

AG Plenus Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

AG Plenus Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being handled by 1 distinct examiner in 1 distinct art unit, which points to a focused prosecution strategy. The company's current patent office activity is concentrated, requiring a precise response to the specific issues raised by the assigned examiner. This focus within the Biotechnology & Pharmaceuticals field suggests that the company is prioritizing a specific innovation or protecting a key piece of its intellectual property portfolio.

JOHNSON, DANIELLE D is the busiest examiner for this portfolio, with 1 pending office action under review. This single action accounts for the company's entire pending workload at this time. Because the portfolio involves only 1 distinct examiner and 1 distinct art unit, the practitioner can dedicate resources to the specific nuances of this case. Successfully resolving the 1 pending office action will require a deep understanding of the requirements of the assigned examiner and the technical standards of the 1 distinct art unit. The company's immediate future in the Biotechnology & Pharmaceuticals sector is closely tied to the resolution of this 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JOHNSON, DANIELLE D 1 45.0% +13.2%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18025401 HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF JOHNSON, DANIELLE D —

Top Art Units

Art UnitApps
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18025401 HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF JOHNSON, DANIELLE D 1617 §103Other Final Rejection — Pending Mar 09, 2023

Managing AG Plenus Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does AG Plenus Ltd. have?

AG Plenus Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most AG Plenus Ltd. applications?

Danielle D Johnson has the most, with 1 of AG Plenus Ltd.'s pending office actions.

What technology area are AG Plenus Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month